{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:38:57Z","timestamp":1793320737369,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES010563"],"award-info":[{"award-number":["ES010563"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES016931"],"award-info":[{"award-number":["ES016931"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES028084"],"award-info":[{"award-number":["ES028084"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12035-019-01824-1","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T03:02:18Z","timestamp":1575428538000},"page":"1570-1593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Manganese Acts upon Insulin\/IGF Receptors to Phosphorylate AKT and Increase Glucose Uptake in Huntington\u2019s Disease Cells"],"prefix":"10.1007","volume":"57","author":[{"given":"Miles R.","family":"Bryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen D.","family":"Nordham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.R.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra M.","family":"Foshage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe M.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Nitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Uhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-3346","authenticated-orcid":false,"given":"Aaron B.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"1824_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-nutr-071714-034419","volume":"35","author":"KJ Horning","year":"2015","unstructured":"Horning KJ, Caito SW, Tipps KG, Bowman AB, Aschner M (2015) Manganese is essential for neuronal health. Annu Rev Nutr 35:71\u2013108","journal-title":"Annu Rev Nutr"},{"key":"1824_CR2","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1074\/jbc.275.11.7803","volume":"275","author":"DW Chan","year":"2000","unstructured":"Chan DW et al (2000) Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine\/threonine protein kinase. J Biol Chem 275:7803\u20137810","journal-title":"J Biol Chem"},{"key":"1824_CR3","doi-asserted-by":"publisher","first-page":"12783","DOI":"10.1074\/jbc.M809207200","volume":"284","author":"T Sato","year":"2009","unstructured":"Sato T, Nakashima A, Guo L, Tamanoi F (2009) Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J Biol Chem 284:12783\u201312791","journal-title":"J Biol Chem"},{"key":"1824_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neulet.2005.12.067","volume":"398","author":"J-H Bae","year":"2006","unstructured":"Bae J-H, Jang BC, Suh SI, Ha E, Baik HH, Kim SS, Lee MY, Shin DH (2006) Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K\/Akt pathways in BV2 microglial cells. Neurosci Lett 398:151\u2013154","journal-title":"Neurosci Lett"},{"key":"1824_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/toxsci\/kfq308","volume":"119","author":"T Cai","year":"2011","unstructured":"Cai T, Che H, Yao T, Chen Y, Huang C, Zhang W, du K, Zhang J et al (2011) Manganese Induces Tau hyperphosphorylation through the activation of ERK MAPK pathway in PC12 Cells. Toxicol Sci 119:169\u2013177","journal-title":"Toxicol Sci"},{"key":"1824_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jat.1552","volume":"31","author":"PL Crittenden","year":"2011","unstructured":"Crittenden PL, Filipov NM (2011) Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells. J Appl Toxicol : JAT 31:1\u201310","journal-title":"J Appl Toxicol : JAT"},{"issue":"5","key":"1824_CR7","doi-asserted-by":"publisher","first-page":"e94753","DOI":"10.1371\/journal.pone.0094753","volume":"9","author":"Vernat Exil","year":"2014","unstructured":"Exil V et al (2014) Activation of MAPK and FoxO by manganese (Mn) in rat neonatal primary astrocyte cultures. PloS one 9","journal-title":"PLoS ONE"},{"key":"1824_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tiv.2008.11.005","volume":"23","author":"B-CC Jang","year":"2009","unstructured":"Jang B-CC (2009) Induction of COX-2 in human airway cells by manganese: role of PI3K\/PKB, p38 MAPK, PKCs, Src, and glutathione depletion. Toxicology in vitro : an international journal published in association with BIBRA 23:120\u2013126","journal-title":"Toxicology in vitro : an international journal published in association with BIBRA"},{"key":"1824_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/syn.20877","volume":"65","author":"SA McDougall","year":"2011","unstructured":"McDougall SA, Der-Ghazarian T, Britt CE, Varela FA, Crawford CA (2011) Postnatal manganese exposure alters the expression of D2L and D2S receptor isoforms: relationship to PKA activity and Akt levels. Synapse (New York, N.Y.) 65:583\u2013591","journal-title":"Synapse (New York, N.Y.)"},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1210\/en.2016-1090","volume":"157","author":"VK Srivastava","year":"2016","unstructured":"Srivastava VK, Hiney JK, Dees WL (2016) Manganese-stimulated kisspeptin is mediated by the IGF-1\/Akt\/mammalian target of rapamycin pathway in the prepubertal female rat. Endocrinology 157:3233\u20133241","journal-title":"Endocrinology"},{"key":"1824_CR11","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1046\/j.1471-4159.1998.71041607.x","volume":"71","author":"Y Hirata","year":"1998","unstructured":"Hirata Y, Adachi K, Kiuchi K (1998) Activation of JNK pathway and induction of apoptosis by manganese in PC12 cells. J Neurochem71:1607\u20131615","journal-title":"J Neurochem"},{"key":"1824_CR12","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1097\/00001756-199809140-00022","volume":"9","author":"Y Hirata","year":"1998","unstructured":"Hirata Y, Adachi K, Kiuchi K (1998) Phosphorylation and activation of p70 S6 kinase by manganese in PC12 cells. Neuroreport 9:3037\u20133040","journal-title":"Neuroreport"},{"key":"1824_CR13","doi-asserted-by":"publisher","first-page":"21113","DOI":"10.1038\/srep21113","volume":"6","author":"Y Tai","year":"2016","unstructured":"Tai Y, Chew KCM, Tan BWQ, Lim K-L, Soong T (2016) Iron mitigates DMT1-mediated manganese cytotoxicity via the ASK1-JNK signaling axis: implications of iron supplementation for manganese toxicity. Sci Rep6:21113","journal-title":"Sci Rep"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/hmg\/ddu609","volume":"24","author":"AM Tidball","year":"2015","unstructured":"Tidball AM, Bryan MR, Uhouse MA, Kumar KK, Aboud AA, Feist JE, Ess KC, Neely MD et al (2015) A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington\u2019s disease. Hum Mol Genet 24:1929\u20131944","journal-title":"Hum Mol Genet"},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/toxsci\/kfr091","volume":"122","author":"JA Moreno","year":"2011","unstructured":"Moreno JA, Streifel KM, Sullivan KA, Hanneman WH, Tjalkens RB (2011) Manganese-induced NF-\u03baB activation and nitrosative stress is decreased by estrogen in juvenile mice. Toxicol Sci122:121\u2013133","journal-title":"Toxicol Sci"},{"issue":"12","key":"1824_CR16","doi-asserted-by":"publisher","first-page":"e21969","DOI":"10.1002\/jbt.21969","volume":"31","author":"Lei Wang","year":"2017","unstructured":"Wang L et al (2017) The effect of postnatal manganese exposure on the NMDA receptor signaling pathway in rat hippocampus. J Biochem Mol Toxicol 31","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"1824_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/nen.0b013e31812503cf","volume":"66","author":"DP Perl","year":"2007","unstructured":"Perl DP, Olanow WC (2007) The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 66:675\u2013682","journal-title":"J Neuropathol Exp Neurol"},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.3390\/ijerph120707519","volume":"12","author":"GF Kwakye","year":"2015","unstructured":"Kwakye GF, Paoliello M, Mukhopadhyay S, Bowman AB, Aschner M (2015) Manganese-induced Parkinsonism and Parkinson\u2019s disease: shared and distinguishable features. Int J Environ Res Public Health 12:7519\u20137540","journal-title":"Int J Environ Res Public Health"},{"key":"1824_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1196\/annals.1306.018","volume":"1012","author":"CW Olanow","year":"2004","unstructured":"Olanow CW (2004) Manganese-induced Parkinsonism and Parkinson\u2019s disease. Ann N Y Acad Sci1012:209\u2013223","journal-title":"Ann N Y Acad Sci"},{"key":"1824_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-2009-0995","volume":"16","author":"M Tong","year":"2009","unstructured":"Tong M, Dong M, de la Monte SM (2009) Brain insulin-like growth factor and neurotrophin resistance in Parkinson\u2019s disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. Journal of Alzheimer\u2019s disease : JAD 16:585\u2013599","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0165-0173(02)00234-5","volume":"41","author":"A Takeda","year":"2003","unstructured":"Takeda A (2003) Manganese action in brain function. Brain Res Rev41:79\u201387","journal-title":"Brain Res Rev"},{"key":"1824_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/aheh.200400556","volume":"33","author":"HH Dieter","year":"2005","unstructured":"Dieter HH, Bayer TA, Multhaup G (2005) Environmental copper and manganese in the pathophysiology of neurologic diseases (Alzheimer\u2019s Disease and Manganism). Acta Hydrochim Hydrobiol 33:72\u201378","journal-title":"Acta Hydrochim Hydrobiol"},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.shaw.2013.07.003","volume":"4","author":"RM Park","year":"2013","unstructured":"Park RM (2013) Neurobehavioral deficits and Parkinsonism in occupations with manganese exposure: a review of methodological issues in the epidemiological literature. Saf Health Work 4:123\u2013135","journal-title":"Saf Health Work"},{"key":"1824_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0022-510X(98)00289-5","volume":"162","author":"S Nagatomo","year":"1999","unstructured":"Nagatomo S, Umehara F, Hanada K, Nobuhara Y, Takenaga S, Arimura K, Osame M (1999) Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci 162:102\u2013105","journal-title":"J Neurol Sci"},{"key":"1824_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.neuro.2012.01.005","volume":"33","author":"RG Lucchini","year":"2012","unstructured":"Lucchini RG, Guazzetti S, Zoni S, Donna F, Peter S, Zacco A, Salmistraro M, Bontempi E et al (2012) Tremor, olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese emission. NeuroToxicology 33:687\u2013696","journal-title":"NeuroToxicology"},{"issue":"3","key":"1824_CR26","doi-asserted-by":"publisher","first-page":"e33057","DOI":"10.1371\/journal.pone.0033057","volume":"7","author":"Fabiano M. Cordova","year":"2012","unstructured":"Cordova FM et al (2012) In Vivo Manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS ONE 7","journal-title":"PLoS ONE"},{"key":"1824_CR27","doi-asserted-by":"crossref","unstructured":"Bryan MR et al (2017) Phosphatidylinositol 3 kinase (PI3K) modulates manganese homeostasis and manganese-induced cell signaling in a murine striatal cell line. NeuroToxicology","DOI":"10.1016\/j.neuro.2017.07.026"},{"key":"1824_CR28","doi-asserted-by":"crossref","unstructured":"Cheng H et al (2018) PI3K\/Akt signaling pathway and Hsp70 activate in hippocampus of rats with chronic manganese sulfate exposure. J Trace Elem Med Biol","DOI":"10.1016\/j.jtemb.2018.07.019"},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00204-013-1017-5","volume":"87","author":"FM Cordova","year":"2013","unstructured":"Cordova FM, Aguiar AS Jr, Peres TV, Lopes MW, Gon\u00e7alves FM, Pedro DZ, Lopes SC, Pilati C et al (2013) Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox. Arch Toxicol 87:1231\u20131244","journal-title":"Arch Toxicol"},{"key":"1824_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","volume":"8","author":"K Acevedo-Torres","year":"2009","unstructured":"Acevedo-Torres K, Berr\u00edos L, Rosario N, Dufault V, Skatchkov S, Eaton MJ, Torres-Ramos CA, Ayala-Torres S (2009) Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington\u2019s disease. DNA Repair 8:126\u2013136","journal-title":"DNA Repair"},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.expneurol.2011.06.016","volume":"231","author":"AI Duarte","year":"2011","unstructured":"Duarte AI, Petit GH, Ranganathan S, Li JY, Oliveira CR, Brundin P, Bj\u00f6rkqvist M, Rego AC (2011) IGF-1 protects against diabetic features in an in vivo model of Huntington\u2019s disease. Exp Neurol 231:314\u2013319","journal-title":"Exp Neurol"},{"key":"1824_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0006-8993(00)01988-0","volume":"859","author":"J Guan","year":"2000","unstructured":"Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P (2000) N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 859:286\u2013292","journal-title":"Brain Res"},{"key":"1824_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(01)02344-8","volume":"316","author":"D Offen","year":"2001","unstructured":"Offen D, Shtaif B, Hadad D, Weizman A, Melamed E, Gil-Ad I (2001) Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson\u2019s disease. Neurosci Lett 316:129\u2013132","journal-title":"Neurosci Lett"},{"key":"1824_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","volume":"209","author":"AD Ebert","year":"2007","unstructured":"Ebert AD, Beres AJ, Barber AE, Svendsen CN (2007) Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson\u2019s disease. Exp Neurol 209:213\u2013223","journal-title":"Exp Neurol"},{"key":"1824_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/dneu.20609","volume":"68","author":"A Quesada","year":"2008","unstructured":"Quesada A, Lee BY, Micevych PE (2008) PI3 kinase\/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson\u2019s disease. Dev Neurobiol 68:632\u2013644","journal-title":"Dev Neurobiol"},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/jnnp.2009.175752","volume":"81","author":"J Godau","year":"2010","unstructured":"Godau J, Herfurth M, Kattner B, Gasser T, Berg D (2010) Increased serum insulin-like growth factor 1 in early idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 81:536\u2013538","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1824_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","volume":"118","author":"F Bassil","year":"2014","unstructured":"Bassil F, Fernagut P-O, Bezard E, Meissner WG (2014) Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification? Prog Neurobiol 118:1\u201318","journal-title":"Prog Neurobiol"},{"key":"1824_CR38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/ene.12137","volume":"21","author":"MT Pellecchia","year":"2014","unstructured":"Pellecchia MT et al (2014) Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-na\u00efve Parkinson\u2019s disease. Eur J Neurol21:802\u2013807","journal-title":"Eur J Neurol"},{"key":"1824_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"J-M Lee","year":"2015","unstructured":"Lee J-M et al (2015) Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162:516\u2013526","journal-title":"Cell"},{"issue":"3","key":"1824_CR40","doi-asserted-by":"publisher","first-page":"e0150552","DOI":"10.1371\/journal.pone.0150552","volume":"11","author":"Felix P. Bernhard","year":"2016","unstructured":"Bernhard FP et al (2016) Insulin-Like Growth Factor 1 (IGF-1) in Parkinson\u2019s disease: potential as trait-, progression- and prediction marker and confounding factors. PLOS ONE 11","journal-title":"PLOS ONE"},{"key":"1824_CR41","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00221-016-4572-1","volume":"234","author":"AE Ayadi","year":"2016","unstructured":"Ayadi AE, Zigmond MJ, Smith AD (2016) IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases. Exp Brain Res 234:1863\u20131873","journal-title":"Exp Brain Res"},{"key":"1824_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1006\/nbdi.2000.0311","volume":"7","author":"S Busiguina","year":"2000","unstructured":"Busiguina S, Fernandez AM, Barrios V, Clark R, Tolbert DL, Berciano J, Torres-Aleman I (2000) Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis 7:657\u2013665","journal-title":"Neurobiol Dis"},{"key":"1824_CR43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","volume":"26","author":"L Gasparini","year":"2003","unstructured":"Gasparini L, Xu H (2003) Potential roles of insulin and IGF-1 in Alzheimer\u2019s disease. Trends Neurosci26:404\u2013406","journal-title":"Trends Neurosci"},{"key":"1824_CR44","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1517\/14728222.11.12.1535","volume":"11","author":"I Torres-Aleman","year":"2007","unstructured":"Torres-Aleman I (2007) Targeting insulin-like growth factor-1 to treat Alzheimer\u2019s disease. Expert Opin Ther Targets 11:1535\u20131542","journal-title":"Expert Opin Ther Targets"},{"key":"1824_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/156720509788486527","volume":"6","author":"S Freude","year":"2009","unstructured":"Freude S, Schilbach K, Schubert M (2009) The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer\u2019s disease: from model organisms to human disease. Curr Alzheimer Res 6:213\u2013223","journal-title":"Curr Alzheimer Res"},{"key":"1824_CR46","doi-asserted-by":"crossref","unstructured":"Moloney AM et al (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31","DOI":"10.1016\/j.neurobiolaging.2008.04.002"},{"key":"1824_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.exger.2013.02.025","volume":"48","author":"C Neill","year":"2013","unstructured":"Neill C (2013) PI3-kinase\/Akt\/mTOR signaling: impaired on\/off switches in aging, cognitive decline and Alzheimer\u2019s disease. Exp Gerontol48:647\u2013653","journal-title":"Exp Gerontol"},{"key":"1824_CR48","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.psyneuen.2013.02.006","volume":"38","author":"P Johansson","year":"2013","unstructured":"Johansson P, \u00c5berg D, Johansson JO, Mattsson N, Hansson O, Ahr\u00e9n B, Isgaard J, \u00c5berg ND et al (2013) Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer\u2019s disease. Psychoneuroendocrinology 38:1729\u20131737","journal-title":"Psychoneuroendocrinology"},{"key":"1824_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF02989238","volume":"6","author":"CL Keen","year":"1984","unstructured":"Keen CL, Baly DL, L\u00f6nnerdal B (1984) Metabolic effects of high doses of manganese in rats. Biol Trace Elem Res 6:309\u2013315","journal-title":"Biol Trace Elem Res"},{"key":"1824_CR50","doi-asserted-by":"crossref","unstructured":"Baly DL (1984) Effect of manganese deficiency on insulin secretion and carbohydrate heomostasis in rats. J Nutrition","DOI":"10.1093\/jn\/114.8.1438"},{"key":"1824_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF02795535","volume":"11","author":"DL Baly","year":"1986","unstructured":"Baly DL, Keen CL, Hurley LS (1986) Effects of manganese deficiency on pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity and carbohydrate homeostasis in adult rats. Biol Trace Elem Res11:201\u2013212","journal-title":"Biol Trace Elem Res"},{"key":"1824_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0014-5793(88)80544-1","volume":"239","author":"DL Baly","year":"1988","unstructured":"Baly DL, Lee I, Doshi R (1988) Mechanism of decreased insulinogenesis in manganese-deficient rats. Decreased insulin mRNA levels. FEBS Lett 239:55\u201358","journal-title":"FEBS Lett"},{"key":"1824_CR53","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/jn\/120.9.1075","volume":"120","author":"DL Baly","year":"1990","unstructured":"Baly DL, Schneiderman JS, Garcia-Welsh AL (1990) Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr 120:1075\u20131079","journal-title":"J Nutr"},{"key":"1824_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3181\/00379727-219-44314","volume":"219","author":"MS Clegg","year":"1998","unstructured":"Clegg MS et al (1998) The influence of manganese deficiency on serum IGF-1 and IGF binding proteins in the male rat. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 219:41\u201347","journal-title":"Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)"},{"key":"1824_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2944(85)90064-X","volume":"34","author":"S Subasinghe","year":"1985","unstructured":"Subasinghe S, Greenbaum AL, McLean P (1985) The insulin-mimetic action of Mn2+: involvement of cyclic nucleotides and insulin in the regulation of hepatic hexokinase and glucokinase. Biochem Med34:83\u201392","journal-title":"Biochem Med"},{"key":"1824_CR56","doi-asserted-by":"publisher","first-page":"9994","DOI":"10.1016\/S0021-9258(18)81758-6","volume":"264","author":"BD Morrison","year":"1989","unstructured":"Morrison BD, Feltz SM, Pessin JE (1989) Polylysine specifically activates the insulin-dependent insulin receptor protein kinase. J Biol Chem 264:9994\u201310001","journal-title":"J Biol Chem"},{"key":"1824_CR57","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/toxsci\/kfr057","volume":"121","author":"JK Hiney","year":"2011","unstructured":"Hiney JK, Srivastava VK, Dees WL (2011) Manganese induces IGF-1 and cyclooxygenase-2 gene expressions in the basal hypothalamus during prepubertal female development. Toxicological sciences : an official journal of the Society of Toxicology121:389\u2013396","journal-title":"Toxicological sciences : an official journal of the Society of Toxicology"},{"key":"1824_CR58","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1210\/en.2012-1445","volume":"154","author":"S-H Lee","year":"2013","unstructured":"Lee S-H et al (2013) Manganese supplementation protects against diet-induced diabetes in wild type mice by enhancing insulin secretion. Endocrinology 154:1029\u20131038","journal-title":"Endocrinology"},{"key":"1824_CR59","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1016\/S0021-9258(17)42730-X","volume":"259","author":"M Ueda","year":"1984","unstructured":"Ueda M, Robinson FW, Smith MM, Kono T (1984) Effects of divalent cations on the regulation of insulin-sensitive glucose transport and cAMP phosphodiesterase in adipocytes. Insulin-like effects of divalent cations. J Biol Chem 259:9520\u20139525","journal-title":"J Biol Chem"},{"key":"1824_CR60","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/0006-291X(89)90801-2","volume":"162","author":"RA Mooney","year":"1989","unstructured":"Mooney RA, Green DA (1989) Insulin receptor dephosphorylation in permeabilized adipocytes is inhibitable by manganese and independent of receptor kinase activity. Biochem Biophys Res Commun 162:1200\u20131206","journal-title":"Biochem Biophys Res Commun"},{"key":"1824_CR61","doi-asserted-by":"publisher","first-page":"29825","DOI":"10.1074\/jbc.270.50.29825","volume":"270","author":"B Xu","year":"1995","unstructured":"Xu B, Bird VG, Miller WT (1995) Substrate specificities of the insulin and insulin-like growth factor 1 receptor tyrosine kinase catalytic domains. J Biol Chem 270:29825\u201329830","journal-title":"J Biol Chem"},{"key":"1824_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0006-291X(90)91358-Y","volume":"171","author":"TJ Singh","year":"1990","unstructured":"Singh TJ (1990) Activation of a manganese-dependent membrane protein kinase by serine and tyrosine phosphorylation. Biochem Biophys Res Commun 171:75\u201383","journal-title":"Biochem Biophys Res Commun"},{"key":"1824_CR63","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","volume":"49","author":"C Lopes","year":"2014","unstructured":"Lopes C, Ribeiro M, Duarte AI, Humbert S, Saudou F, Pereira de Almeida L, Hayden M, Rego AC (2014) IGF-1 intranasal administration rescues Huntington\u2019s disease phenotypes in YAC128 mice. Mol Neurobiol 49:1126\u20131142","journal-title":"Mol Neurobiol"},{"key":"1824_CR64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","volume":"74","author":"M Ribeiro","year":"2014","unstructured":"Ribeiro M, Rosenstock TR, Oliveira AM, Oliveira CR, Rego AC (2014) Insulin and IGF-1 improve mitochondrial function in a PI-3 K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med74:129\u2013144","journal-title":"Free Radic Biol Med"},{"key":"1824_CR65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","volume":"51","author":"L Naia","year":"2015","unstructured":"Naia L, Ferreira IL, Cunha-Oliveira T, Duarte AI, Ribeiro M, Rosenstock TR, La\u00e7o MN, Ribeiro MJ et al (2015) Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington\u2019s Disease human lymphoblasts. Mol Neurobiol 51:331\u2013348","journal-title":"Mol Neurobiol"},{"key":"1824_CR66","doi-asserted-by":"crossref","unstructured":"Naia L et al (2016) Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin. Neuropeptides","DOI":"10.1016\/j.npep.2016.01.009"},{"key":"1824_CR67","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1083\/jcb.200510065","volume":"172","author":"A Yamamoto","year":"2006","unstructured":"Yamamoto A, Cremona ML, Rothman JE (2006) Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172:719\u2013731","journal-title":"J Cell Biol"},{"key":"1824_CR68","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/S0140-6736(72)91092-6","volume":"299","author":"S Podolsky","year":"1972","unstructured":"Podolsky S, Leopold N, Sax D (1972) Increased frequency of diabetes mellitus in patients with Huntington\u2019s chorea. Lancet 299:1356\u20131359","journal-title":"Lancet"},{"key":"1824_CR69","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","volume":"27","author":"LA Farrer","year":"1985","unstructured":"Farrer LA (1985) Diabetes mellitus in Huntington disease. Clin Genet27:62\u201367","journal-title":"Clin Genet"},{"key":"1824_CR70","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","volume":"48","author":"MS Hurlbert","year":"1999","unstructured":"Hurlbert MS, Zhou W, Wasmeier C, Kaddis FG, Hutton JC, Freed CR (1999) Mice transgenic for an expanded CAG repeat in the Huntington\u2019s disease gene develop diabetes. Diabetes 48:649\u2013651","journal-title":"Diabetes"},{"key":"1824_CR71","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain114:1953\u20131975","journal-title":"Brain"},{"key":"1824_CR72","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"DH Rosas","year":"2008","unstructured":"Rosas DH et al (2008) Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain131:1057\u20131068","journal-title":"Brain"},{"key":"1824_CR73","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","volume":"69","author":"DH Rosas","year":"2012","unstructured":"Rosas DH et al (2012) Alterations in brain transition metals in Huntington disease: an evolving and intricate story. Arch Neurol 69:887\u2013893","journal-title":"Arch Neurol"},{"key":"1824_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/toxsci\/kfq174","volume":"117","author":"BB Williams","year":"2010","unstructured":"Williams BB, Kwakye GF, Wegrzynowicz M, Li D, Aschner M, Erikson KM, Bowman AB (2010) Altered manganese homeostasis and manganese toxicity in a Huntington\u2019s disease striatal cell model are not explained by defects in the iron transport system. Toxicological sciences : an official journal of the Society of Toxicology 117:169\u2013179","journal-title":"Toxicological sciences : an official journal of the Society of Toxicology"},{"key":"1824_CR75","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.neuro.2011.01.002","volume":"32","author":"GF Kwakye","year":"2011","unstructured":"Kwakye GF, Li D, Bowman AB (2011) Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington\u2019s disease confirms a deficit in manganese accumulation. NeuroToxicology 32:630\u2013639","journal-title":"NeuroToxicology"},{"key":"1824_CR76","doi-asserted-by":"crossref","unstructured":"Madison JL, Wegrzynowicz M, Aschner M, Bowman AB (2012) Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PloS one7","DOI":"10.1371\/journal.pone.0031024"},{"key":"1824_CR77","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.bbadis.2017.02.013","volume":"1863","author":"TV Bichell","year":"2017","unstructured":"Bichell TV et al (2017) Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington\u2019s disease mouse model. Biochim Biophys Acta (BBA) - Mol Basis Dis 1863:1596\u20131604","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"1824_CR78","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1471-4159.2009.06445.x","volume":"112","author":"BB Williams","year":"2010","unstructured":"Williams BB, Li D, Wegrzynowicz M, Vadodaria BK, Anderson JG, Kwakye GF, Aschner M, Erikson KM et al (2010) Disease-toxicant screen reveals a neuroprotective interaction between Huntington\u2019s disease and manganese exposure. J Neurochem 112:227\u2013237","journal-title":"J Neurochem"},{"key":"1824_CR79","doi-asserted-by":"crossref","unstructured":"Pfalzer AC, Wages PA, Porter NA, Bowman AB (2019) Striatal cholesterol precursors are altered with age in female Huntington\u2019s disease model mice. Journal of Huntington\u2019s disease","DOI":"10.3233\/JHD-180321"},{"issue":"4","key":"1824_CR80","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"Konrad Talbot","year":"2012","unstructured":"Talbot K et al (2012) Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122","journal-title":"Journal of Clinical Investigation"},{"key":"1824_CR81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuro.2014.01.010","volume":"41","author":"AB Bowman","year":"2014","unstructured":"Bowman AB, Aschner M (2014) Considerations on manganese (Mn) treatments for in vitro studies. NeuroToxicology 41:141\u2013142","journal-title":"NeuroToxicology"},{"key":"1824_CR82","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","volume":"21","author":"E Colin","year":"2005","unstructured":"Colin E, R\u00e9gulier E, Perrin V, D\u00fcrr A, Brice A, Aebischer P, D\u00e9glon N, Humbert S et al (2005) Akt is altered in an animal model of Huntington\u2019s disease and in patients. Eur J Neurosci 21:1478\u20131488","journal-title":"Eur J Neurosci"},{"key":"1824_CR83","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1093\/hmg\/ddn281","volume":"17","author":"D Zala","year":"2008","unstructured":"Zala D, Colin E, Rangone H, Liot G, Humbert S, Saudou F (2008) Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet17:3837\u20133846","journal-title":"Hum Mol Genet"},{"key":"1824_CR84","doi-asserted-by":"publisher","first-page":"17235","DOI":"10.1074\/jbc.M110.118620","volume":"285","author":"J Boucher","year":"2010","unstructured":"Boucher J, Tseng Y-H, Kahn RC (2010) Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription. J Biol Chem 285:17235\u201317245","journal-title":"J Biol Chem"},{"issue":"1","key":"1824_CR85","doi-asserted-by":"publisher","first-page":"a009191","DOI":"10.1101\/cshperspect.a009191","volume":"6","author":"J. Boucher","year":"2014","unstructured":"Boucher J, Kleinridders A, Kahn RC (2014) Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol 6","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1824_CR86","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1021\/jm050392q","volume":"48","author":"M Wittman","year":"2005","unstructured":"Wittman M, Carboni J, Attar R, Balasubramanian B, Balimane P, Brassil P, Beaulieu F, Chang C et al (2005) Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity. J Med Chem48:5639\u20135643","journal-title":"J Med Chem"},{"key":"1824_CR87","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1021\/jm900786r","volume":"52","author":"MD Wittman","year":"2009","unstructured":"Wittman MD et al (2009) Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development. J Med Chem 52:7360\u20137363","journal-title":"J Med Chem"},{"key":"1824_CR88","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4155\/fmc.09.89","volume":"1","author":"MJ Mulvihill","year":"2009","unstructured":"Mulvihill MJ, Cooke A, Rosenfeld-Franklin M, Buck E, Foreman K, Landfair D, O'Connor M, Pirritt C et al (2009) Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. Future Med Chem 1:1153\u20131171","journal-title":"Future Med Chem"},{"key":"1824_CR89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1535-6108(04)00051-0","volume":"5","author":"C Garc\u00eca-Echeverr\u00eca","year":"2004","unstructured":"Garc\u00eca-Echeverr\u00eca C et al (2004) In vivo antitumor activity of NVP-AEW541\u2014a novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5:231\u2013239","journal-title":"Cancer Cell"},{"key":"1824_CR90","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","volume":"61","author":"HP Reddy","year":"2009","unstructured":"Reddy HP, Mao P, Manczak M (2009) Mitochondrial structural and functional dynamics in Huntington\u2019s disease. Brain Res Rev 61:33\u201348","journal-title":"Brain Res Rev"},{"key":"1824_CR91","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","volume":"231","author":"LI Ferreira","year":"2011","unstructured":"Ferreira LI et al (2011) Bioenergetic dysfunction in Huntington\u2019s disease human cybrids. Exp Neurol 231:127\u2013134","journal-title":"Exp Neurol"},{"key":"1824_CR92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","volume":"20","author":"K Josefsen","year":"2007","unstructured":"Josefsen K et al (2007) Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington\u2019s disease. J Neuroendocrinol 20:165\u2013172","journal-title":"J Neuroendocrinol"},{"key":"1824_CR93","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/ncomms3917","volume":"4","author":"AI Acu\u00f1a","year":"2013","unstructured":"Acu\u00f1a AI et al (2013) A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington\u2019s disease in mice. Nat Commun 4:2917","journal-title":"Nat Commun"},{"key":"1824_CR94","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clin Investig 121:493\u2013499","journal-title":"J Clin Investig"},{"key":"1824_CR95","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00726-017-2417-2","volume":"49","author":"V Morea","year":"2017","unstructured":"Morea V et al (2017) Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure? Amino Acids 49:1147\u20131157","journal-title":"Amino Acids"},{"key":"1824_CR96","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","volume":"29","author":"SE Browne","year":"2004","unstructured":"Browne SE, Beal FM (2004) The energetics of Huntington\u2019s disease. Neurochem Res 29:531\u2013546","journal-title":"Neurochem Res"},{"key":"1824_CR97","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","volume":"39","author":"A Ciarmiello","year":"2012","unstructured":"Ciarmiello A et al (2012) 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Med Mol Imaging 39:1030\u20131036","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1824_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/JOE-11-0200","volume":"211","author":"H Yan","year":"2011","unstructured":"Yan H, Mitschelen M, Bixler GV, Brucklacher RM, Farley JA, Han S, Freeman WM, Sonntag WE (2011) Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J Endocrinol 211:27\u201337","journal-title":"J Endocrinol"},{"key":"1824_CR99","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC (2007) AKT\/PKB signaling: navigating downstream. Cell 129:1261\u20131274","journal-title":"Cell"},{"key":"1824_CR100","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0167-4889(95)00032-N","volume":"1267","author":"V Chauhan","year":"1995","unstructured":"Chauhan V, Singh SS, Chauhan A, Brockerhoff H (1995) Phosphatidylinositol 3-kinase: inhibition of intrinsic protein-serine kinase activity by phosphoinositides, and of lipid kinase activity by Mn2+. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1267:139\u2013144","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"1824_CR101","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/toxsci\/kfm095","volume":"98","author":"D Milatovic","year":"2007","unstructured":"Milatovic D, Yin Z, Gupta RC, Sidoryk M, Albrecht J, Aschner JL, Aschner M (2007) Manganese Induces oxidative impairment in cultured rat astrocytes. Toxicol Sci 98:198\u2013205","journal-title":"Toxicol Sci"},{"key":"1824_CR102","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.taap.2009.07.004","volume":"240","author":"D Milatovic","year":"2009","unstructured":"Milatovic D, Zaja-Milatovic S, Gupta RC, Yu Y, Aschner M (2009) Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol 240:219\u2013225","journal-title":"Toxicol Appl Pharmacol"},{"key":"1824_CR103","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/tx9003193","volume":"23","author":"J Pan","year":"2010","unstructured":"Pan J, Chang Q, Wang X, Son Y, Zhang Z, Chen G, Luo J, Bi Y et al (2010) Reactive oxygen species-activated Akt\/ASK1\/p38 signaling pathway in nickel compound-induced apoptosis in BEAS 2B cells. Chem Res Toxicol 23:568\u2013577","journal-title":"Chem Res Toxicol"},{"key":"1824_CR104","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/0008-5472.CAN-03-0737","volume":"64","author":"J Li","year":"2004","unstructured":"Li J, Davidson G, Huang Y, Jiang BH, Shi X, Costa M, Huang C (2004) Nickel compounds act through Phosphatidylinositol-3-kinase\/Akt-dependent, p70S6k-Independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal Cl41 Cells. Cancer Res 64:94\u2013101","journal-title":"Cancer Res"},{"key":"1824_CR105","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1006\/abbi.2001.2559","volume":"397","author":"EA Ostrakhovitch","year":"2002","unstructured":"Ostrakhovitch EA, Lordnejad M, Schliess F, Sies H, Klotz L-O (2002) Copper ions strongly activate the phosphoinositide-3-Kinase\/Akt pathway independent of the generation of reactive oxygen species. Arch Biochem Biophys 397:232\u2013239","journal-title":"Arch Biochem Biophys"},{"key":"1824_CR106","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.abb.2007.04.015","volume":"463","author":"A Barthel","year":"2007","unstructured":"Barthel A, Ostrakhovitch EA, Walter PL, Kampk\u00f6tter A, Klotz L-O (2007) Stimulation of phosphoinositide 3-kinase\/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 463:175\u2013182","journal-title":"Arch Biochem Biophys"},{"key":"1824_CR107","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/jn\/131.5.1414","volume":"131","author":"X Tang","year":"2001","unstructured":"Tang X, Shay NF (2001) Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr131:1414\u20131420","journal-title":"J Nutr"},{"key":"1824_CR108","first-page":"6","volume-title":"Journal of the American Chemical Society","author":"WR Bidlack","year":"1996","unstructured":"Bidlack WR (1996) The Biological Chemistry of Magnesium. In: Cowan JA (ed) Journal of the American Chemical Society, vol 118. (The Ohio State University). VCH Publishers, Inc., New York. 1995. xvi + 254 pp. $59.95. ISBN 1-56081-627-9, pp. 6\u20137"},{"key":"1824_CR109","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1021\/bi901726c","volume":"49","author":"B Lovitt","year":"2010","unstructured":"Lovitt B, Vanderporten EC, Sheng Z, Zhu H, Drummond J, Liu Y (2010) Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2). Biochemistry 49:3092\u20133100","journal-title":"Biochemistry"},{"key":"1824_CR110","doi-asserted-by":"crossref","unstructured":"Maydan M et al (2010) Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) phosphorylation. PLoS ONE 5","DOI":"10.1371\/journal.pone.0012356"},{"key":"1824_CR111","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","volume":"2","author":"S Humbert","year":"2002","unstructured":"Humbert S et al (2002) The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2:831\u2013837","journal-title":"Dev Cell"},{"key":"1824_CR112","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1100\/tsw.2006.22","volume":"6","author":"DN Aberg","year":"2006","unstructured":"Aberg DN, Brywe K, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. TheScientificWorldJournal 6:53\u201380","journal-title":"TheScientificWorldJournal"},{"key":"1824_CR113","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10571-012-9891-6","volume":"33","author":"X-X Fang","year":"2013","unstructured":"Fang X-X, Jiang X-L, Han X-H, Peng Y-P, Qiu Y-H (2013) Neuroprotection of Interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK\/STAT3, MAPK\/ERK, and PI3K\/AKT signaling pathways. Cell Mol Neurobiol 33:241\u2013251","journal-title":"Cell Mol Neurobiol"},{"key":"1824_CR114","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/cdd.2015.11","volume":"22","author":"C Bl\u00e1zquez","year":"2015","unstructured":"Bl\u00e1zquez C et al (2015) The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway. Cell Death Differ 22:1618\u20131629","journal-title":"Cell Death Differ"},{"key":"1824_CR115","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuint.2016.03.010","volume":"97","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Ye J, Wei N, Fong C, Dong X (2016) Protection against MPP+-induced neurotoxicity in SH-SY5Y cells by tormentic acid via the activation of PI3-K\/Akt\/GSK3\u03b2 pathway. Neurochem Int97:117\u2013123","journal-title":"Neurochem Int"},{"key":"1824_CR116","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S1043-2760(02)00662-8","volume":"13","author":"EL Whiteman","year":"2002","unstructured":"Whiteman EL, Cho H, Birnbaum MJ (2002) Role of Akt\/protein kinase B in metabolism. Trends Endocrinol Metab 13:444\u2013451","journal-title":"Trends Endocrinol Metab"},{"key":"1824_CR117","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A et al (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain 119:2085\u20132095","journal-title":"Brain"},{"key":"1824_CR118","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","volume":"113","author":"T Kuwert","year":"1990","unstructured":"Kuwert T et al (1990) Cortical and subcortical glucose consumption measured by pet in patients with Huntington\u2019s disease. Brain113:1405\u20131423","journal-title":"Brain"},{"key":"1824_CR119","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.410200305","volume":"20","author":"AB Young","year":"1986","unstructured":"Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, Ehrenkaufer R, Jewett D et al (1986) PET scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 20:296\u2013303","journal-title":"Ann Neurol"},{"key":"1824_CR120","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ana.410230603","volume":"23","author":"S Berent","year":"1988","unstructured":"Berent S, Giordani B, Lehtinen S, Markel D, Penney JB, Buchtel HA, Starosta-Rubinstein S, Hichwa R et al (1988) Positron emission tomographic scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of cognitive function. Ann Neurol 23:541\u2013546","journal-title":"Ann Neurol"},{"key":"1824_CR121","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1212\/WNL.36.7.888","volume":"36","author":"MR Hayden","year":"1986","unstructured":"Hayden MR et al (1986) Positron emission tomography in the early diagnosis of Huntington\u2019s disease. Neurology 36:888\u2013888","journal-title":"Neurology"},{"key":"1824_CR122","first-page":"215","volume":"47","author":"A Ciarmiello","year":"2006","unstructured":"Ciarmiello A et al (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 47:215\u2013222","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"1824_CR123","first-page":"1591","volume":"42","author":"A Feigin","year":"2001","unstructured":"Feigin A et al (2001) Metabolic network abnormalities in early Huntington\u2019s disease: an [(18)F]FDG PET study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 42:1591\u20131595","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"1824_CR124","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1566-2772(03)00057-4","volume":"3","author":"S Humbert","year":"2003","unstructured":"Humbert S, Saudou F (2003) Huntingtin phosphorylation and signaling pathways that regulate toxicity in Huntington\u2019s disease. Clin Neurosci Res 3:149\u2013155","journal-title":"Clin Neurosci Res"},{"key":"1824_CR125","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M, Dompierre JP, Rangone H, Cordeli\u00e8res FP, de Mey J, MacDonald M et al (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"1824_CR126","doi-asserted-by":"publisher","first-page":"14318","DOI":"10.1523\/JNEUROSCI.1589-10.2010","volume":"30","author":"M Metzler","year":"2010","unstructured":"Metzler M, Gan L, Mazarei G, Graham RK, Liu L, Bissada N, Lu G, Leavitt BR et al (2010) Phosphorylation of Huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A. J Neurosci 30:14318\u201314329","journal-title":"J Neurosci"},{"key":"1824_CR127","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ et al (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1\u03b1 in Huntington\u2019s disease neurodegeneration. Cell Metab 4:349\u2013362","journal-title":"Cell Metab"},{"key":"1824_CR128","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.2337\/db06-0030","volume":"55","author":"AI Duarte","year":"2006","unstructured":"Duarte AI, Proen\u00e7a T, Oliveira CR, Santos MS, Rego AC (2006) Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 55:2863\u20132870","journal-title":"Diabetes"},{"key":"1824_CR129","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","volume":"85","author":"JH Lee","year":"2014","unstructured":"Lee JH et al (2014) Reinstating aberrant mTORC1 activity in Huntington\u2019s disease mice improves disease phenotypes. Neuron 85:303\u2013315","journal-title":"Neuron"},{"key":"1824_CR130","doi-asserted-by":"crossref","unstructured":"Culbreth M, Zhang Z, A.-M (2017) Neurotoxicology, methylmercury augments Nrf2 activity by downregulation of the Src family kinase Fyn. Neurotoxicology","DOI":"10.1016\/j.neuro.2017.07.028"},{"key":"1824_CR131","doi-asserted-by":"crossref","unstructured":"Allen JW, Mutkus LA, Aschner M (2000) Isolation of neonatal rat cortical astrocytes for primary cultures. Curr Protocols Toxicol 4","DOI":"10.1002\/0471140856.tx1204s04"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01824-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-019-01824-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01824-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T22:12:30Z","timestamp":1650406350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-019-01824-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":131,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01824-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"16 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The datasets during and\/or analyzed during the current study will be made available using the Dryad data repository.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and Material Availability"}}]}}